Glimepiride
Product Images NDC 66116-432

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glimepiride (NDC 66116-432). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medvantx, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (3f626e54 B043 4556 9568 Ace556cff9e9 01)

Chemical structure diagram of Glimepiride showing its molecular components and bonds in blue lines. The image clearly depicts the arrangement of atoms within the Glimepiride molecule.*

FDA Label Image

Glimepiride 2mg Tablet (3f626e54 B043 4556 9568 Ace556cff9e9 02)

Glimepiride Tablets, USP 2 mg bottle label showing 30 tablets. The label includes dosage instructions space, an expiration date placeholder, lot number, and NDC 66116-432-30. Manufactured by Teva Pharmaceutical Industries Ltd., Jerusalem, Israel, and distributed by MedVantx, Inc., San Diego, CA. Instructions to store at controlled room temperature (20°-25°C) and warnings to keep the container tightly closed and out of reach of children are shown. The label states Rx Only and sample use not for sale.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.